从国际合作伙伴转移大规模的艾滋病毒/艾滋病治疗计划到当地尼日利亚的执行合作伙伴:一个前后早期结果评估研究
David Ochedomi Ekele1, Inichinbia Boniface1, Bonaventure Michael Ukoaka2
1Excellence Community Education Welfare Scheme (ECEWS), Abuja, Nigeria.
BMC health services research
|October 2, 2025
概括
将艾滋病毒/艾滋病计划转移给尼日利亚当地合作伙伴,如ECEWS,成功地维护和改善了服务提供和结果. 这项研究展示了尼日利亚可持续艾滋病毒治疗的有效模式,确保在不影响质量的情况下保持连续性.
科学领域:
- 公共卫生 公共卫生
- 全球健康 全球健康
- 加强卫生系统 加强卫生系统
背景情况:
- 全球对艾滋病毒/艾滋病的应对在很大程度上依赖于国际援助,PEPFAR (美国政府) 是主要的贡献者,特别是在全球南部.
- PEPFAR正在转向可持续性,将艾滋病毒/艾滋病治疗计划转移给当地合作伙伴,特别是在低收入和中等收入国家.
- 在尼日利亚等国家,这些过渡的有效模式和结果的证据有限.
研究的目的:
- 评估一项大规模的艾滋病毒/艾滋病计划从国际实施者 (FHI 360) 转移到尼日利亚的当地合作伙伴 (ECEWS).
- 突出这一过渡的过程和早期成果.
- 评估对服务可访问性,护理质量和治疗结果的影响.
主要方法:
- 一项前后研究设计分析了来自尼日利亚阿克瓦伊博姆州和克罗斯河州的程序数据.
- 对比关键绩效指标 (艾滋病毒检测,按计划补充,病毒载量检测) 转型前和转型后 (2022年1月至12月).
- 利用来自电子医疗记录和DHIS2的非身份化客户数据,在STATA中进行统计分析.
主要成果:
- 过渡后,艾滋病毒检测增加了149% (每月检测量从19356个增加到48260个).
- 按时间安排的补充预约从97.8%提高到98.2% (p<0.001).
- 病毒载量测试的普及率从96%上升到99%,这是由于一个强大的过渡模式,包括利益相关者参与和M&E.
结论:
- 在不影响服务质量或结果的情况下,成功地将艾滋病毒/艾滋病计划转移给尼日利亚当地合作伙伴是可以实现的.
- 协作规划和结构化过渡模式对于维持计划绩效至关重要.
- 这项研究为尼日利亚和其他资源有限的环境中类似的过渡提供了战略框架.
更多相关视频
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.1K
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
2.7K
相关概念视频
Community Based Intervention
277
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
277
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Nursing Evaluation
4.2K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
4.2K
